Beam Therapeutics Inc (BEAM)

Cost of Revenue

$0.00

TTM · Period ending: · USD

BEAM logo

BEAM Cost of Revenue

Latest reported$0.00
BEAM TTM Cost of Revenue ($33.87M → $0.00)
High-resolution chart · PNG

BEAM cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Beam Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
0
0
0
0
0
0
84,818,000
224,895,000
324,945,000
422,553,000
437,381,000
383,645,000
368,882,000
345,830,000
311,594,000
167,081,000
136,417,000
107,438,000
232,134,000
322,757,000
297,959,000
271,736,000
103,179,000
90,945,000
73,663,000
66,989,000
54,619,000
47,854,000
41,565,000
35,968,500
33,873,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.